相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Tocotrienol as a potential anticancer agent
Ming T. Ling et al.
CARCINOGENESIS (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Genome-Wide Somatic Copy Number Alterations in Low-Grade PanINs and IPMNs from Individuals with a Family History of Pancreatic Cancer
Seung-Mo Hong et al.
CLINICAL CANCER RESEARCH (2012)
Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals
Marcia Irene Canto et al.
GASTROENTEROLOGY (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Identification of germline genomic copy number variation in familial pancreatic cancer
Wigdan Al-Sukhni et al.
HUMAN GENETICS (2012)
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice
Altaf Mohammed et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells
Xiangming Ji et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway
Sonyo Shin-Kang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Vitamin E δ-Tocotrienol Augments the Antitumor Activity of Gemcitabine and Suppresses Constitutive NF-κB Activation in Pancreatic Cancer
Kazim Husain et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy
Seung Tae Kim et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Cystic precursors to invasive pancreatic cancer
Hanno Matthaei et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy
F. Kullmann et al.
ONCOLOGY (2011)
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways
Jian Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases
Bharat B. Aggarwal et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer
Ferdinandos Skoulidis et al.
CANCER CELL (2010)
The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model
Altaf Mohammed et al.
CANCER PREVENTION RESEARCH (2010)
Anti-proliferative effects of γ-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression
G. V. Samant et al.
CELL PROLIFERATION (2010)
被撤回的出版物: γ-Tocotrienol but Not γ-Tocopherol Blocks STAT3 Cell Signaling Pathway through Induction of Protein-tyrosine Phosphatase SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents (Retracted article. See vol. 291, pg. 16922, 2016)
Ramaswamy Kannappan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
d-δ-Tocotrienol-Mediated Suppression of the Proliferation of Human PANC-1, MIA PaCa-2, and BxPC-3 Pancreatic Carcinoma Cells
Deema Hussein et al.
PANCREAS (2009)
Vitamin E delta-Tocotrienol Levels in Tumor and Pancreatic Tissue of Mice after Oral Administration
Kazim Husain et al.
PHARMACOLOGY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Delayed progression of pancreatic intraepithelial neoplasia in a conditional KrasG12D mouse model by a selective cyclooxygenase-2 inhibitor
Hitoshi Funahashi et al.
CANCER RESEARCH (2007)
Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplilications, and KRAS mutations on survival of pancreatic adenocarcinoma
Jeeyun Lee et al.
CANCER (2007)
γ-tocotrienol inhibits nuclear factor-κB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and Potentiation of apoptosis
Kwang Seok Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by δ- and γ-tocotrienols
Bao-Liang Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pharmacologic inhibition of RAF→MEK→ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1
S Gysin et al.
CANCER RESEARCH (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
分享论文
